The clinical course of a man with an apparently isolated deficiency of pituitary gonadotrophin is described. Despite interstitial cell stimulation, prolonged therapy with human chorionic gonadotrophin did not produce spermatogenesis. In contrast, 60 days after treatment with human pituitary gonadotrophin had started, viable spermatozoa were seen and spermatogenesis was subsequently maintained for 16 months.
INTRODUCTION
In recent years there have been several reports of the use of human gonadotrophin to stimulate spermatogenesis in the treatment of complete gonadotrophin deficiency following total hypophysectomy (Gemzell & Kjessler, 1964; Macleod, Pazianos & Ray, 1964; Macleod, Pazianos & Ray, 1966) or craniopharyngioma (Lytton & Kase, 1966) . In addition Lunenfeld, Mor, Mani & Zinberg (1965) (Martin, 1964) The sperm count rose steadily to a level of 25,000,000 8 months after treatment had started. The volume of ejaculate varied from 1-5 to 2-5 ml., the motility from 30 to 70 % and the percentage of abnormal forms from 10 to 50 % on different occasions.
In July 1965, 12 months after commencing treatment it was decided to double the dose of HPG to approximately 1500 i.u. FSH/week. This was done because there seemed to be a slight decline in the seminal count at this time, and because the patient's wife had not become pregnant although her menses were regular and ovula¬ tory by temperature chart. After 1 month on this increased dose, HCG was withdrawn because of concern that peritubular fibrosis might have been induced and treatment with HPG was continued alone at a dose of 1500 units/week for a further 2 months. The sperm count rose to the previous peak level and was maintained with an ejaculate of 2-5-5-0 ml., motility 30-50% and abnormal forms 10-20%, but while off HCG libido decreased and treatment with 500 i.u. HCG/week was re-started which pro¬ vided adequate stimulation. At the same time, since no apparent effect on spermato¬ genesis had been observed with the increased dose, HPG was reduced to 500 i.u./ week. This regime was continued for a further 10 weeks with maintenance of spermato¬ genesis at much the same level as before but a decrease in ejaculate to 1-5-2-0 ml. During the whole of this 15-month period of treatment the patient and his wife had failed to achieve pregnancy despite careful advice and satisfactory intercourse, and both began to show features of anxiety which included exacerbation of the patient's epigastric pain and an irregular anovulatory menstrual cycle in his wife.
Since the continuation of treatment was placing a severe strain on the available supplies of HPG, the possibility that maintenance could be achieved by one injection per week instead of two or three was considered. The 
